Comparative Pharmacology
Head-to-head clinical analysis: LAX LYTE WITH FLAVOR PACKS versus SODIUM PICOSULFATE MAGNESIUM OXIDE AND ANHYDROUS CITRIC ACID.
Peer-Reviewed Evidence
Head-to-head clinical analysis: LAX LYTE WITH FLAVOR PACKS versus SODIUM PICOSULFATE MAGNESIUM OXIDE AND ANHYDROUS CITRIC ACID.
LAX-LYTE WITH FLAVOR PACKS vs SODIUM PICOSULFATE, MAGNESIUM OXIDE AND ANHYDROUS CITRIC ACID
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Osmotic laxative: polyethylene glycol (PEG) retains water in the intestinal lumen, increasing stool volume and stimulating peristalsis. Electrolytes (sodium, potassium, chloride, bicarbonate) prevent electrolyte depletion.
Sodium picosulfate is a stimulant laxative that is converted by colonic bacteria to the active metabolite bis-(p-hydroxyphenyl)-pyridyl-2-methane, which acts on the colonic mucosa to stimulate peristalsis and increase water and electrolyte secretion. Magnesium oxide and citric acid react in solution to form magnesium citrate, an osmotic laxative that draws water into the intestinal lumen, increasing stool volume and promoting bowel evacuation.
Oral: 1 to 2 packets (4 to 8 g of polyethylene glycol 3350) dissolved in 4 to 8 ounces of water once daily, as needed for constipation. Maximum: 2 packets per day.
Adults: 10 mg sodium picosulfate, 3.5 g magnesium oxide, and 10.97 g anhydrous citric acid (reconstituted in water) as a single oral dose, followed by clear liquids. Two doses may be used in a split-dose regimen: first dose evening before procedure, second dose day of procedure at least 5 hours prior.
None Documented
None Documented
Terminal elimination half-life is 6-8 hours in patients with normal renal function; prolonged in renal impairment (up to 20 hours).
Sodium picosulfate active metabolite BHPM: terminal half-life approximately 7.4 hours; clinical duration of laxative effect extends beyond half-life due to colonic residence.
Primarily renal (30-50% unchanged) and biliary/fecal (50-70% as inactive metabolites).
Sodium picosulfate is primarily excreted in feces (biliary/fecal elimination) as active metabolite BHPM; <5% renal. Magnesium oxide is excreted renally as magnesium ions; absorbed magnesium is eliminated via kidneys. Anhydrous citric acid is metabolized in the Krebs cycle; minimal renal excretion.
Category C
Category C
Laxative
Laxative